Carbohydrate repression of catalase synthesis in Bacteroides fragilis.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMC 234954)

Published in J Bacteriol on January 01, 1977

Authors

E M Gregory, B J Veltri, D L Wagner, T D Wilkins

Articles by these authors

(truncated to the top 100)

Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38

Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35

Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29

Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26

Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88

Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44

Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1979) 5.10

Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62

Development of a micromethod for identification of anaerobic bacteria. Appl Microbiol (1975) 4.58

Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09

Induction of superoxide dismutase by molecular oxygen. J Bacteriol (1973) 4.09

Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06

Superoxide dismutases of Escherichia coli: intracellular localization and functions. J Bacteriol (1973) 3.96

Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95

Host specificity of Lepidoptera in tropical and temperate forests. Nature (2007) 3.85

Micromethod for identification of anaerobic bacteria: design and operation of apparatus. Appl Microbiol (1975) 3.80

Oxygen toxicity and the superoxide dismutase. J Bacteriol (1973) 3.66

Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40

Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93

Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89

Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86

Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol (1976) 2.67

Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65

Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum. J Infect Dis (1970) 2.62

Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49

Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46

Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46

Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun (1972) 2.43

Superoxide dismutase and oxygen toxicity in a eukaryote. J Bacteriol (1974) 2.42

Ninety-seven million years of angiosperm-insect association: paleobiological insights into the meaning of coevolution. Proc Natl Acad Sci U S A (1994) 2.32

Visualization of catalase on acrylamide gels. Anal Biochem (1974) 2.18

Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun (1982) 2.14

The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun (1995) 2.06

Oxygen metabolism in Lactobacillus plantarum. J Bacteriol (1974) 2.03

Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01

Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00

Purification and characterization of an enterotoxin from Bacteroides fragilis. Infect Immun (1992) 1.97

Commercial latex test for Clostridium difficile toxin A does not detect toxin A. J Clin Microbiol (1986) 1.92

Differential effects of Clostridium difficile toxins on tissue-cultured cells. J Clin Microbiol (1982) 1.87

Resistance of some species of Clostridium to clindamycin. Antimicrob Agents Chemother (1973) 1.81

Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics. Antimicrob Agents Chemother (1978) 1.78

In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother (1975) 1.78

Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin. J Clin Microbiol (1982) 1.75

Chemotherapy of an experimental Fusobacterium (Sphaerophorus) necrophorum infection in mice. Antimicrob Agents Chemother (1974) 1.71

Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol (1991) 1.67

Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect Immun (1991) 1.66

Fibrinolytic activity of oral anaerobic bacteria. Arch Oral Biol (1978) 1.65

Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect Immun (1976) 1.65

Toxin A of Clostridium difficile is a potent cytotoxin. J Clin Microbiol (1990) 1.65

Use of semisolid agar from initiation of pure Bacteroides fragilis infection in mice. Infect Immun (1976) 1.64

Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology (1996) 1.63

Inhibition of Bacteroides fragilis on blood agar plates and reversal of inhibition by added hemin. J Clin Microbiol (1976) 1.63

Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis. Antimicrob Agents Chemother (1977) 1.62

Laminarinase (beta-glucanase) activity in Bacteroides from the human colon. Appl Environ Microbiol (1977) 1.61

Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo. Infect Immun (1995) 1.59

Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin. Infect Immun (1987) 1.57

Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity. Infect Immun (1986) 1.57

Requirement of heme for growth of Bacteroides fragilis. Appl Environ Microbiol (1977) 1.53

Clostridium difficile toxin A in infants. J Infect Dis (1983) 1.53

Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal Gal alpha 1-3Gal beta 1-4GlcNAc sequences. Arch Biochem Biophys (1987) 1.51

Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.50

Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infect Immun (1987) 1.47

Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile. J Med Microbiol (1992) 1.47

The Bacteroides fragilis toxin fragilysin disrupts the paracellular barrier of epithelial cells. Infect Immun (1997) 1.46

Cytochrome spectrum of an obligate anaerobe, Eubacterium lentum. J Bacteriol (1976) 1.45

Bacteriophages of Bacteroides. Rev Infect Dis (1980) 1.44

Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infect Immun (1991) 1.44

Clostridium perfringens iota toxin: synergism between two proteins. Toxicon (1986) 1.43

Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate. Infect Immun (1991) 1.42

Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol (1977) 1.40

Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun (1988) 1.40

Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol (1976) 1.39

Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. FEMS Microbiol Lett (1997) 1.36

Characterization of cross-reactive proteins detected by Culturette Brand Rapid Latex Test for Clostridium difficile. J Clin Microbiol (1988) 1.34

Comparison of culture, cytotoxicity assays, and enzyme-linked immunosorbent assay for toxin A and toxin B in the diagnosis of Clostridium difficile-related enteric disease. Diagn Microbiol Infect Dis (1986) 1.34

Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun (1992) 1.32

Superoxide dismutase and O2 lethality in Bacteroides fragilis. J Bacteriol (1979) 1.27

Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing. Antimicrob Agents Chemother (1978) 1.26

Rabbit sucrase-isomaltase contains a functional intestinal receptor for Clostridium difficile toxin A. J Clin Invest (1996) 1.26

Superoxide dismutase in anaerobes: survey. Appl Environ Microbiol (1978) 1.26

Active Fe-containing superoxide dismutase and abundant sodF mRNA in Nostoc commune (Cyanobacteria) after years of desiccation. J Bacteriol (2000) 1.23

Isolation of auxotrophs of Bacteroides fragilis. Can J Microbiol (1978) 1.21

High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C. Proc Natl Acad Sci U S A (1992) 1.20

Positive regulation of Clostridium difficile toxins. Infect Immun (1997) 1.17

Bacteriocin production by strains of Bacteroides isolated from human feces and the role of these strains in the bacterial ecology of the colon. Antimicrob Agents Chemother (1977) 1.16

Fat of Coxiella burnetti in macrophages from immune guinea pigs. Infect Immun (1977) 1.16

Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology (1983) 1.15

Production and some properties of catalase and superoxide dismutase from the anaerobe Bacteroides distasonis. J Bacteriol (1977) 1.14

Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity. Microb Pathog (1994) 1.14

TechLab and alexon Giardia enzyme-linked immunosorbent assay kits detect cyst wall protein 1. J Clin Microbiol (1999) 1.13

Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation. J Clin Pharmacol (1999) 1.13

Role of Clostridium difficile toxins in disease. Gastroenterology (1987) 1.11

The fecapentaenes, potent mutagens from human feces. Chem Res Toxicol (1992) 1.11

Effect of high-fiber and high-oil diets on the fecal flora of swine. Appl Environ Microbiol (1987) 1.10

Characterization of the O2-induced manganese-containing superoxide dismutase from Bacteroides fragilis. Arch Biochem Biophys (1985) 1.09

Isolation of iron-containing superoxide dismutase from Bacteroides fragilis: reconstitution as a Mn-containing enzyme. Arch Biochem Biophys (1983) 1.09

Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases. Infect Immun (1989) 1.09

Degradation of polysaccharides by intestinal bacterial enzymes. Am J Clin Nutr (1978) 1.07

Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect Immun (1998) 1.06

Transparent plastic incubator for the anaerobic glove box. Appl Environ Microbiol (1977) 1.06